{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:14:14Z","timestamp":1791976454232,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00228-024-03706-5","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T07:02:27Z","timestamp":1719039747000},"page":"1503-1514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-4376","authenticated-orcid":false,"given":"Miguel-\u00c1ngel","family":"Maci\u00e1-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8280-7489","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Castillo-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-3992","authenticated-orcid":false,"given":"Patricia","family":"Garc\u00eda-Poza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3576-8605","authenticated-orcid":false,"given":"Elisa","family":"Mart\u00edn-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,22]]},"reference":[{"key":"3706_CR1","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. AEMPS (2022) Ficha t\u00e9cnica Nolotil 575 mg c\u00e1psulas duras. https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/47633\/FT_47633.html. Accessed 6 Jun 2024"},{"issue":"11","key":"3706_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00228-004-0836-y","volume":"60","author":"L Ib\u00e1\u00f1ez","year":"2005","unstructured":"Ib\u00e1\u00f1ez L, Vidal X, Ballar\u00edn E, Laporte JR (2005) Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 60(11):821\u2013829","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"3706_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","volume":"71","author":"M Huber","year":"2015","unstructured":"Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M et al (2015) Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 71(2):219\u2013227","journal-title":"Eur J Clin Pharmacol"},{"issue":"13","key":"3706_CR4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","volume":"256","author":"Risks of agranulocytosis and aplastic anemia","year":"1986","unstructured":"Risks of agranulocytosis and aplastic anemia (1986) A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 256(13):1749\u20131757","journal-title":"JAMA"},{"issue":"4","key":"3706_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"58","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58(4):265\u2013274","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"3706_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bcpt.13310","volume":"126","author":"F Hoffmann","year":"2020","unstructured":"Hoffmann F, Bantel C, Jobski K (2020) Agranulocytosis attributed to metamizole: an analysis of spontaneous reports in EudraVigilance 1985\u20132017. Basic Clin Pharmacol Toxicol 126(2):116\u2013125","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"3706_CR7","first-page":"299","volume":"110","author":"E Andr\u00e8s","year":"2017","unstructured":"Andr\u00e8s E, Mourot-Cottet R, Maloisel F, S\u00e9verac F, Keller O, Vogel T et al (2017) Idiosyncratic drug-induced neutropenia & agranulocytosis. QJM Mon J Assoc Physicians 110(5):299\u2013305","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"9","key":"3706_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146(9):657\u2013665","journal-title":"Ann Intern Med"},{"key":"3706_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bcp.2019.01.011","volume":"163","author":"D Rudin","year":"2019","unstructured":"Rudin D, Lanzilotto A, Bachmann F, Housecroft CE, Constable EC, Drewe J et al (2019) Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells. Biochem Pharmacol 163:345\u2013356","journal-title":"Biochem Pharmacol"},{"issue":"426","key":"3706_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2019.152254","volume":"1","author":"D Rudin","year":"2019","unstructured":"Rudin D, Roos NJ, Duthaler U, Kr\u00e4henb\u00fchl S (2019) Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes. Toxicology 1(426):152254","journal-title":"Toxicology"},{"issue":"1","key":"3706_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2478\/pjvs-2014-0030","volume":"17","author":"A Jasiecka","year":"2014","unstructured":"Jasiecka A, Ma\u015blanka T, Jaroszewski JJ (2014) Pharmacological characteristics of metamizole. Pol J Vet Sci 17(1):207\u2013214","journal-title":"Pol J Vet Sci"},{"key":"3706_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.727717","volume":"12","author":"B Rattay","year":"2021","unstructured":"Rattay B, Benndorf RA (2021) Drug-induced idiosyncratic agranulocytosis - infrequent but dangerous. Front Pharmacol 12:727717","journal-title":"Front Pharmacol"},{"issue":"8","key":"3706_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejim.2006.07.012","volume":"17","author":"E Andr\u00e8s","year":"2006","unstructured":"Andr\u00e8s E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F (2006) Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med 17(8):529\u2013535","journal-title":"Eur J Intern Med"},{"issue":"4","key":"3706_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00210-019-01774-4","volume":"393","author":"S Klose","year":"2020","unstructured":"Klose S, Pflock R, K\u00f6nig IR, Linder R, Schwaninger M (2020) Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data. Naunyn Schmiedebergs Arch Pharmacol 393(4):681\u2013690","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3706_CR15","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. AEMPS (2018) Fentanilo de liberaci\u00f3n inmediata: importancia de respetar las condiciones de uso autorizadas.\u00a0https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2018\/ni-muh_fv_5-2017-fentanilo\/. Accessed 6 Jun 2024"},{"issue":"10","key":"3706_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/pds.5006","volume":"29","author":"MA Maci\u00e1-Mart\u00ednez","year":"2020","unstructured":"Maci\u00e1-Mart\u00ednez MA, Gil M, Huerta C, Mart\u00edn-Merino E, \u00c1lvarez A, Bryant V et al (2020) Base de Datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria (BIFAP): a data resource for pharmacoepidemiology in Spain. Pharmacoepidemiol Drug Saf 29(10):1236\u20131245","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"3706_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jclinepi.2009.07.001","volume":"63","author":"H Gardarsdottir","year":"2010","unstructured":"Gardarsdottir H, Souverein PC, Egberts TCG, Heerdink ER (2010) Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol 63(4):422\u2013427","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"3706_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archinte.165.8.869","volume":"165","author":"L Ib\u00e1\u00f1ez","year":"2005","unstructured":"Ib\u00e1\u00f1ez L, Vidal X, Ballar\u00edn E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165(8):869\u2013874","journal-title":"Arch Intern Med"},{"issue":"22","key":"3706_CR19","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2146\/ajhp070369","volume":"65","author":"T Gerhard","year":"2008","unstructured":"Gerhard T (2008) Bias: considerations for research practice. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 65(22):2159\u20132168","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"key":"3706_CR20","unstructured":"Coates TD (2022) Drug-induced neutropenia and agranulocytosis - UpToDate.\u00a0https:\/\/sso.uptodate.com\/contents\/drug-induced-neutropenia-and-agranulocytosis?search=agranulocitosis%20por%20medicamentos&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Accessed 12 Jul 2023"},{"issue":"3","key":"3706_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0960327115580603","volume":"35","author":"R Navarro-Mart\u00ednez","year":"2016","unstructured":"Navarro-Mart\u00ednez R, Chover-Sierra E, Cauli O (2016) Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital. Hum Exp Toxicol 35(3):244\u2013250","journal-title":"Hum Exp Toxicol"},{"issue":"5","key":"3706_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0897190014546115","volume":"27","author":"AM Pick","year":"2014","unstructured":"Pick AM, Nystrom KK (2014) Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit? J Pharm Pract 27(5):447\u2013452","journal-title":"J Pharm Pract"},{"issue":"S7","key":"3706_CR23","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1002\/pds.2630020706","volume":"2","author":"DW Kaufman","year":"1993","unstructured":"Kaufman DW, Kelly JP, Levy M, Shapiro S (1993) The drug etiology of agranulocytosis: an update of the international agranulocytosis and aplastic anemia study. Pharmacoepidemiol Drug Saf 2(S7):S25\u2013S29","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"3706_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ajh.10295","volume":"72","author":"TP Van Staa","year":"2003","unstructured":"Van Staa TP, Boulton F, Cooper C, Hagenbeek A, Inskip H, Leufkens HGM (2003) Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol 72(4):248\u2013254","journal-title":"Am J Hematol"},{"key":"3706_CR25","unstructured":"Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J (2011) Harrison\u2019s principles of internal medicine, 18th edn. McGraw Hill Professional"},{"issue":"4","key":"3706_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archinte.159.4.369","volume":"159","author":"MM van der Klauw","year":"1999","unstructured":"van der Klauw MM, Goudsmit R, Halie MR, van\u2019t Veer MB, Herings RM, Wilson JH, et al (1999) A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 159(4):369\u201374","journal-title":"Arch Intern Med."},{"issue":"9","key":"3706_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00228-008-0513-7","volume":"64","author":"N Hamerschlak","year":"2008","unstructured":"Hamerschlak N, Maluf E, Biasi Cavalcanti A, Avezum J\u00fanior A, Eluf-Neto J, Passeto Falc\u00e3o R et al (2008) Incidence and risk factors for agranulocytosis in Latin American countries\u2013the Latin Study: a multicenter study. Eur J Clin Pharmacol 64(9):921\u2013929","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3706_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.4269\/ajtmh.1999.60.573","volume":"60","author":"S Shapiro","year":"1999","unstructured":"Shapiro S, Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T et al (199AD) Agranulocytosis in Bangkok Thailand a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 60(4):573\u20137","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"3706_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","volume":"71","author":"LS Blaser","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P, Haschke M, Kr\u00e4henb\u00fchl S, R\u00e4tz Bravo AE (2015) Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol 71(2):209\u2013217","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"3706_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/EJA.0000000000000272","volume":"32","author":"M Fieler","year":"2015","unstructured":"Fieler M, Eich C, Becke K, Badelt G, Leimk\u00fchler K, Messroghli L et al (2015) Metamizole for postoperative pain therapy in 1177 children: a prospective, multicentre, observational, postauthorisation safety study. Eur J Anaesthesiol 32(12):839\u2013843","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"3706_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jcpt.12422","volume":"41","author":"S Andrade","year":"2016","unstructured":"Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J (2016) Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther 41(5):459\u2013477","journal-title":"J Clin Pharm Ther"},{"key":"3706_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1600-0609.1996.tb01641.x","volume":"60","author":"DW Kaufman","year":"1996","unstructured":"Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE et al (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 60:23\u201330","journal-title":"Eur J Haematol Suppl"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03706-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T06:08:44Z","timestamp":1726121324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03706-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3706"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03706-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,22]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective study conducted on data registered in BIFAP. The use of BIFAP data for this project was approved by the BIFAP Scientific Committee (reference number 18\u20132020) and by the Ethics Committee \u201cComit\u00e9 de \u00e9tica de la investigaci\u00f3n con medicamentos regional de la Comunidad de Madrid (CEIM-R)\u201d (reference number BIFAP_18_2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. The investigators had access only to secondary use of pseudonymized data, and under this condition, consent of study subjects is not required according to the Spanish law.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}